SIONNA THERAPEUTICS INCSION
ASignal's systematic analysis rates SION as Neutral.
Reflects the latest available analysis · analyzed Oct 11, 2026
The case on SION
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong cash position with $211.03M in total cash
- Low debt-to-equity ratio of 0.03x indicating minimal leverage risk
- High current and quick ratios (20.05x and 19.57x) signaling strong liquidity
- RSI at 18.02 indicating deeply oversold conditions
- Price trading near lower Bollinger Band suggesting potential reversal
- Negative free cash flow of -$45.44M and operating cash flow of -$75.92M
- Negative return on equity (-32.34%) and return on assets (-21.54%)
- Zero operating, net, and gross margins
- Negative EV/EBITDA of -0.17x and negative forward P/E of -2.20x indicating unprofitability
- Limited news coverage from only one source (Yahoo) and no Reddit mentions
See the full verdict on SION
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes SION
Most investors never get a second opinion, let alone several. ASignal runs SION past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.